Perpetual LTD Autolus Therapeutics PLC Transaction History
Perpetual LTD
- $10.2 Trillion
- Q1 2024
A detailed history of Perpetual LTD transactions in Autolus Therapeutics PLC stock. As of the latest transaction made, Perpetual LTD holds 2,234,515 shares of AUTL stock, worth $9.36 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
2,234,515
Previous 2,234,515
-0.0%
Holding current value
$9.36 Million
Previous $14.3 Billion
-0.0%
% of portfolio
0.14%
Previous 0.14%
Shares
5 transactions
Others Institutions Holding AUTL
# of Institutions
123Shares Held
168MCall Options Held
411KPut Options Held
67.6K-
Syncona Portfolio LTD Guernsey, Channel Islands, X021.3MShares$89.4 Million90.76% of portfolio
-
Blackstone Inc New York, NY20.5MShares$85.8 Million0.54% of portfolio
-
Deep Track Capital, LP Greenwich, CT15.3MShares$64 Million3.22% of portfolio
-
Avoro Capital Advisors LLC New York, NY12.3MShares$51.7 Million0.95% of portfolio
-
Wellington Management Group LLP Boston, MA10.8MShares$45.1 Million0.01% of portfolio
About Autolus Therapeutics plc
- Ticker AUTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 90,909,800
- Market Cap $381M
- Description
- Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...